MBFJF
MITSUBISHI UFJ FINANCIAL GROUP INC
$19.89
+1.22%
No data for this timeframe.
Vol
SEC Reports4
Recent Activity
Jun 1, 2026
SEC
MUFG disclosed progress on its ¥100 billion share repurchase program authorized on May 15, 2026. Through May 31, 2026, t
6-K — Impact 5/10
May 29, 2026
SEC
Mitsubishi UFJ Financial Group filed a Form 6-K with the SEC for May 2026. The filing contains no material financial dat
6-K — Impact 2/10
Apr 21, 2026
SEC
MUFG completed a $5.5 billion debt offering consisting of five tranches of senior callable notes with maturities from 20
6-K — Impact 4/10
Analyst Ratings
3Strong Buy
12Buy
4Hold
0Sell
0Strong Sell
Latest Reports
BULLISH
6-K
5/10
MUFG disclosed progress on its ¥100 billion share repurchase program authorized on May 15, 2026. Through May 31, 2026, t
Jun 1, 2026
NEUTRAL
6-K
2/10
Mitsubishi UFJ Financial Group filed a Form 6-K with the SEC for May 2026. The filing contains no material financial dat
May 29, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
4 SEC filing reports analyzed. Sentiment: 1 bullish, 0 bearish, 0 mixed, 3 neutral. Avg impact: 3.8/10.
BULLISH
6-K
5/10
MUFG disclosed progress on its ¥100 billion share repurchase program authorized on May 15, 2026. Thr
Jun 1, 2026
NEUTRAL
6-K
2/10
Mitsubishi UFJ Financial Group filed a Form 6-K with the SEC for May 2026. The filing contains no ma
May 29, 2026
NEUTRAL
6-K
4/10
MUFG completed a $5.5 billion debt offering consisting of five tranches of senior callable notes wit
Apr 21, 2026
NEUTRAL
424B5
4/10
MUFG is issuing multiple series of senior callable debt notes with maturities ranging from 2030 to 2
Apr 8, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 79% buy across 19 analysts — 3 strong buy, 12 buy, 4 hold, 0 sell, 0 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $1630.7B | 20.0% | — |
| Next FY 2028-03-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $6836.0B | 88.2% | — |
| Next Q 2026-09-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $1638.1B | 3.9% | — |
| Current FY 2027-03-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $6415.8B | 104.0% | — |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 3 | 12 | 4 | 0 | 0 | 79% | |
| May 1, 2026 | 3 | 12 | 4 | 0 | 0 | 79% | |
| Apr 1, 2026 | 3 | 12 | 4 | 0 | 0 | 79% | |
| Mar 1, 2026 | 3 | 12 | 4 | 0 | 0 | 79% | |
| Feb 1, 2026 | 4 | 11 | 4 | 0 | 0 | 79% | |
| Jan 1, 2026 | 3 | 11 | 4 | 0 | 0 | 78% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.